Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Berman

Showing results (401-410 of 459) with videos related to

Pageof 46
Sort By:
The American Journal of Pathology|January 12, 2002
CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrilsIndra Sethy Coraci, Jens Husemann, Joan W Berman, et al.
Journal of Virology|July 1, 1992
Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1P W Berman, T J Matthews, L Riddle, et al.
AIDS Research and Human Retroviruses|October 31, 2003
Microglia from mice transgenic for a provirus encoding a monocyte-tropic HIV type 1 isolate produce infectious virus and display in vitro and in vivo upregulation of lipopolysaccharide-induced chemokine gene expressionEmilie-Jeanne Wang, Jinglin Sun, Massimo Pettoello-Mantovani, et al.
Virology|December 22, 1999
Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and ThailandP W Berman, W Huang, L Riddle, et al.
The Journal of Infectious Diseases|August 19, 2005
HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccinePeter B Gilbert, Marta L Ackers, Phillip W Berman, et al.
The Journal of Biological Chemistry|February 22, 2000
Human vascular smooth muscle cells possess functional CCR5A D Schecter, T M Calderon, A B Berman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1980
Embryonic-fetal erythroid characteristics of a human leukemic cell lineE J Benz, M J Murnane, B L Tonkonow, et al.
AIDS Research and Human Retroviruses|November 1, 1992
Genetic variants of HIV-1 in ThailandF E McCutchan, P A Hegerich, T P Brennan, et al.
Journal of Virology|August 31, 2012
Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodiesSara M O'Rourke, Becky Schweighardt, Pham Phung, et al.
AIDS (London, England)|May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzeesP W Berman, D J Eastman, D M Wilkes, et al.
Pageof 46

Showing results (401-410 of 459) with videos related to

Sort By:
Pageof 46
The American Journal of Pathology|January 12, 2002
CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrilsIndra Sethy Coraci, Jens Husemann, Joan W Berman, et al.
Journal of Virology|July 1, 1992
Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1P W Berman, T J Matthews, L Riddle, et al.
AIDS Research and Human Retroviruses|October 31, 2003
Microglia from mice transgenic for a provirus encoding a monocyte-tropic HIV type 1 isolate produce infectious virus and display in vitro and in vivo upregulation of lipopolysaccharide-induced chemokine gene expressionEmilie-Jeanne Wang, Jinglin Sun, Massimo Pettoello-Mantovani, et al.
Virology|December 22, 1999
Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and ThailandP W Berman, W Huang, L Riddle, et al.
The Journal of Infectious Diseases|August 19, 2005
HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccinePeter B Gilbert, Marta L Ackers, Phillip W Berman, et al.
The Journal of Biological Chemistry|February 22, 2000
Human vascular smooth muscle cells possess functional CCR5A D Schecter, T M Calderon, A B Berman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1980
Embryonic-fetal erythroid characteristics of a human leukemic cell lineE J Benz, M J Murnane, B L Tonkonow, et al.
AIDS Research and Human Retroviruses|November 1, 1992
Genetic variants of HIV-1 in ThailandF E McCutchan, P A Hegerich, T P Brennan, et al.
Journal of Virology|August 31, 2012
Sequences in glycoprotein gp41, the CD4 binding site, and the V2 domain regulate sensitivity and resistance of HIV-1 to broadly neutralizing antibodiesSara M O'Rourke, Becky Schweighardt, Pham Phung, et al.
AIDS (London, England)|May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzeesP W Berman, D J Eastman, D M Wilkes, et al.
Pageof 46